Topic | Gender | N (%) | Crude OR (95% CI) | P-value | Adjusted ORa (95% CI) | P-value |
---|---|---|---|---|---|---|
Pain | Female | 24/74 (32) | 1.0 (ref) | 1.0 (ref) | ||
Male | 22/86 (26) | 0.7 (0.4–1.4) | 0.35 | 0.7 (0.4–1.5) | 0.37 | |
Fatigue | Female | 32/74 (43) | 1.0 | 1.0 | ||
Male | 31/86 (36) | 0.7 (0.4–1.4) | 0.42 | 0.8 (0.4–1.5) | 0.41 | |
Bowel/urination | Female | 4/74 (5) | 1.0 | 1.0 | ||
Male | 3/86 (4) | 0.6 (0.1–2.9) | 0.56 | 0.6 (0.1–3.0) | 0.57 | |
Sexual | Female | 9/74 (12) | 1.0 | 1.0 | ||
Male | 11/86 (13) | 1.1 (0.4–2.7) | 0.90 | 1.1 (0.4–2.9) | 0.83 | |
Mobility | Female | 15/74 (20) | 1.0 | 1.0 | ||
Male | 21/86 (24) | 1.3 (0.6–2.7) | 0.53 | 1.2 (0.6–2.8) | 0.48 | |
Psychological | Female | 8/74 (11) | 1.0 | 1.0 | ||
Male | 11/86 (13) | 1.2 (0.5–3.2) | 0.70 | 1.3 (0.5–3.4) | 0.63 | |
Other | Female | 15/74 (20) | 1.0 | 1.0 | ||
Male | 8/86 (9) | 0.4 (0.2–1.0) | 0.05 | 0.4 (0.2–1.0) | 0.05 | |
Peer | Female | 4/74 (5) | 1.0 | 1.0 | ||
Male | 6/86 (7) | 1.3 (0.4–4.8) | 0.68 | 1.3 (0.3–4.8) | 0.79 | |
No topic | Female | 5/74 (7) | 1.0 | 1.0 | 0.05 | |
Male | 14/86 (17) | 2.7 (0.9–8.5) | 0.05 | 2.9 (0.9–8.3) |